Es gab 50 kürzliche Insider-Transaktionen für Kezar Life Sciences, Inc. (KZR), darunter 31 Käufe und 16 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $3.5M und die gesamten Insider-Verkäufe auf $10.62M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Schiller Mark C., Chiang Pichi Luo, To Zung Phuong. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — KZR
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-07-02 |
Schiller Mark C. |
Chief Operating Officer |
Informierter Verkauf |
561 |
$4.28 |
$2.4K |
2,739 |
| 2025-07-02 |
Chiang Pichi Luo |
SVP, Corporate Controller |
Informierter Verkauf |
264 |
$4.28 |
$1.13K |
2,711 |
| 2025-07-01 |
To Zung Phuong |
Chief Development Officer |
RSU-Zuteilung |
7,000 |
$4.40 |
$30.8K |
7,000 |
| 2025-06-18 |
Berger Franklin M |
Director |
RSU-Zuteilung |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Kauffman Michael |
Director |
RSU-Zuteilung |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Cooper Graham K |
Director |
RSU-Zuteilung |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Garner Elizabeth |
Director |
RSU-Zuteilung |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Fowler John Franklin |
Director |
RSU-Zuteilung |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Wallace Courtney |
Director |
RSU-Zuteilung |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-06-18 |
Klearman Micki |
Director |
RSU-Zuteilung |
5,000 |
$4.46 |
$22.3K |
5,000 |
| 2025-04-01 |
Chiang Pichi Luo |
SVP, Corporate Controller |
Unbekannt |
17,500 |
$6.58 |
$115.15K |
- |
| 2025-04-01 |
To Zung Phoung |
SVP, Clinical Development |
Unbekannt |
20,000 |
$6.58 |
$131.6K |
- |
| 2025-03-27 |
Belsky Marc |
Chief Financial Officer |
RSU-Zuteilung |
4,800 |
$6.30 |
$30.24K |
12,000 |
| 2025-03-27 |
Schiller Mark C. |
Chief Legal Officer |
RSU-Zuteilung |
4,800 |
$6.30 |
$30.24K |
12,000 |
| 2025-03-04 |
Belsky Marc |
Chief Financial Officer |
RSU-Zuteilung |
7,200 |
$6.30 |
$45.36K |
7,200 |
| 2025-03-04 |
Schiller Mark C. |
Chief Legal Officer |
RSU-Zuteilung |
7,200 |
$6.30 |
$45.36K |
7,200 |
| 2025-02-14 |
Fowler John Franklin |
Director |
RSU-Zuteilung |
5,000 |
$5.89 |
$29.45K |
5,000 |
| 2025-01-09 |
Belsky Marc |
Chief Financial Officer |
RSU-Zuteilung |
24,500 |
$6.58 |
$161.21K |
24,500 |
| 2025-01-09 |
Kirk Christopher J. |
CEO |
RSU-Zuteilung |
120,000 |
$6.58 |
$789.6K |
120,000 |
| 2025-01-09 |
Schiller Mark C. |
Chief Legal Officer |
RSU-Zuteilung |
24,500 |
$6.58 |
$161.21K |
24,500 |
| 2024-07-02 |
Schiller Mark C. |
Chief Legal Officer |
Informierter Verkauf |
6,688 |
$0.58 |
$3.88K |
33,007 |
| 2024-06-20 |
Berger Franklin M |
Director |
RSU-Zuteilung |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-06-20 |
Kauffman Michael |
Director |
RSU-Zuteilung |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-06-20 |
Cooper Graham K |
Director |
RSU-Zuteilung |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-06-20 |
Garner Elizabeth |
Director |
RSU-Zuteilung |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-06-20 |
Wallace Courtney |
Director |
RSU-Zuteilung |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-06-20 |
Klearman Micki |
Director |
RSU-Zuteilung |
50,000 |
$0.67 |
$33.5K |
50,000 |
| 2024-01-15 |
Schiller Mark C. |
Chief Legal Officer |
Veräußerung |
250,000 |
$0.93 |
$232.5K |
- |
| 2024-01-07 |
Belsky Marc |
Chief Financial Officer |
RSU-Zuteilung |
295,000 |
$0.93 |
$274.35K |
295,000 |
| 2024-01-07 |
Mordwinkin Nicholas Michael |
Chief Business Officer |
RSU-Zuteilung |
275,000 |
$0.93 |
$255.75K |
275,000 |
| 2023-11-08 |
Kirk Christopher J. |
CEO |
RSU-Zuteilung |
875,000 |
$0.84 |
$735K |
875,000 |
| 2023-08-15 |
Morningside Venture Investments Ltd |
10 Percent Owner |
Schenkung (gegeben) |
3,500,000 |
- |
- |
1,947,993 |
| 2023-07-24 |
Berger Franklin M |
Director |
Aktienrückgabe |
26,000 |
$4.80 |
$124.8K |
- |
| 2023-07-24 |
Kauffman Michael |
Director |
Aktienrückgabe |
26,000 |
$4.80 |
$124.8K |
- |
| 2023-07-24 |
Belsky Marc |
Chief Financial Officer |
Aktienrückgabe |
195,000 |
$6.84 |
$1.33M |
- |
| 2023-07-24 |
Cooper Graham K |
Director |
Aktienrückgabe |
26,000 |
$4.80 |
$124.8K |
- |
| 2023-07-24 |
Garner Elizabeth |
Director |
Aktienrückgabe |
26,000 |
$4.80 |
$124.8K |
- |
| 2023-07-24 |
Kirk Christopher J. |
Director |
Aktienrückgabe |
190,000 |
$6.84 |
$1.3M |
- |
| 2023-07-24 |
Fowler John Franklin |
CEO |
Aktienrückgabe |
175,000 |
$22.85 |
$4M |
- |
| 2023-07-24 |
Wallace Courtney |
Director |
Aktienrückgabe |
26,000 |
$4.80 |
$124.8K |
- |
| 2023-07-24 |
Henig Noreen |
Chief Medical Officer |
Aktienrückgabe |
220,000 |
$6.84 |
$1.5M |
- |
| 2023-07-24 |
Klearman Micki |
Director |
Aktienrückgabe |
52,000 |
$5.94 |
$308.88K |
- |
| 2023-07-24 |
Mordwinkin Nicholas Michael |
Chief Business Officer |
Aktienrückgabe |
185,000 |
$6.84 |
$1.27M |
- |
| 2023-07-20 |
Kirk Christopher J. |
Director |
Optionsausübung (Verkauf) |
48,950 |
$0.90 |
$44.06K |
74,411 |
| 2023-06-15 |
Berger Franklin M |
Director |
RSU-Zuteilung |
35,000 |
$2.64 |
$92.4K |
35,000 |
| 2023-06-15 |
Kauffman Michael |
Director |
RSU-Zuteilung |
35,000 |
$2.64 |
$92.4K |
35,000 |
| 2023-06-15 |
Cooper Graham K |
Director |
RSU-Zuteilung |
35,000 |
$2.64 |
$92.4K |
35,000 |
| 2023-06-15 |
Garner Elizabeth |
Director |
RSU-Zuteilung |
35,000 |
$2.64 |
$92.4K |
35,000 |
| 2023-06-15 |
Wallace Courtney |
Director |
RSU-Zuteilung |
35,000 |
$2.64 |
$92.4K |
35,000 |
| 2023-06-15 |
Klearman Micki |
Director |
RSU-Zuteilung |
35,000 |
$2.64 |
$92.4K |
35,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
